|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhao F and Qiao Y: Cervical cancer
prevention in China: A key to cancer control. Lancet. 393:969–970.
2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Brasseur K, Gevry N and Asselin E:
Chemoresistance and targeted therapies in ovarian and endometrial
cancers. Oncotarget. 8:4008–4042. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wu MH, Huang CJ, Liu ST, Liu PY, Ho CL and
Huang SM: Physical and functional interactions of human
papillomavirus E2 protein with nuclear receptor coactivators.
Biochem Biophys Res Commun. 356:523–528. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Remoue F, Jacobs N, Miot V, Boniver J and
Delvenne P: High intraepithelial expression of estrogen and
progesterone receptors in the transformation zone of the uterine
cervix. Am J Obstet Gynecol. 189:1660–1665. 2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Liang J and Shang Y: Estrogen and cancer.
Annual Rev Physiol. 75:225–240. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rosenfeld MG and Glass CK: Coregulator
codes of transcriptional regulation by nuclear receptors. J Biol
Chem. 276:36865–36868. 2001.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang XM, Wu ZM, Huang H, Chu XY, Lou J, Xu
LX, Chen YT, Wang LQ and Huang OP: Estrogen receptor 1 mutations in
260 cervical cancer samples from Chinese patients. Oncol Lett.
18:2771–2776. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sood S, Patel FD, Ghosh S, Arora A,
Dhaliwal LK and Srinivasan R: Epigenetic alteration by DNA
methylation of ESR1, MYOD1 and hTERT Gene promoters is useful for
prediction of response in patients of locally advanced invasive
cervical carcinoma treated by chemoradiation. Clin Oncol (R Coll
Radiol). 27:720–727. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Noël JC, Bucella D, Fayt I, Simonart T,
Buxant F, Anaf V and Simon P: Androgen receptor expression in
cervical intraepithelial neoplasia and invasive squamous cell
carcinoma of the cervix. Int J Gynecol Pathol. 27:437–441.
2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bao W, Wang HH, Tian FJ, He XY, Qiu MT,
Wang JY, Zhang HJ, Wang LH and Wan XP: A TrkB-STAT3-miR-204-5p
regulatory circuitry controls proliferation and invasion of
endometrial carcinoma cells. Mol Cancer. 12(155)2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lv T, Song K, Zhang L, Li W, Chen Y, Diao
Y, Yao Q and Liu P: miRNA-34a decreases ovarian cancer cell
proliferation and chemoresistance by targeting HDAC1. Biochem Cell
Biol. 96:663–671. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
He L, Wang HY, Zhang L, Huang L, Li JD,
Xiong Y, Zhang MY, Jia WH, Yun JP, Luo RZ and Zheng M: Prognostic
significance of low DICER expression regulated by miR-130a in
cervical cancer. Cell Death Dis. 5(e1205)2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bao W, Zhang Y, Li S, Fan Q, Qiu M, Wang
Y, Li Y, Ji X, Yang Y, Sang Z, et al: miR1075p promotes tumor
proliferation and invasion by targeting estrogen receptoralpha in
endometrial carcinoma. Oncol Rep. 41:1575–1585. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wright JD, Matsuo K, Huang Y, Tergas AI,
Hou JY, Khoury-Collado F, St Clair CM, Ananth CV, Neugut AI and
Hershman DL: Prognostic performance of the 2018 international
federation of gynecology and obstetrics cervical cancer staging
guidelines. Obstet Gynecol. 134:49–57. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Fan Q, Qiu MT, Zhu Z, Zhou JH, Chen L,
Zhou Y, Gu W, Wang LH, Li ZN, Xu Y, et al: Twist induces
epithelial-mesenchymal transition in cervical carcinogenesis by
regulating the TGF-β/Smad3 signaling pathway. Oncol Rep.
34:1787–1794. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bao W, Qiu H, Yang T, Luo X, Zhang H and
Wan X: Upregulation of TrkB promotes epithelial-mesenchymal
transition and anoikis resistance in endometrial carcinoma. PLoS
One. 8(e70616)2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Pan Y, Wang R, Zhang F, Chen Y, Lv Q, Long
G and Yang K: MicroRNA-130a inhibits cell proliferation, invasion
and migration in human breast cancer by targeting the RAB5A. Int J
Clin Exp Pathol. 8:384–393. 2015.PubMed/NCBI
|
|
22
|
Zheng L, Kang Y, Zhang L and Zou W:
MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation
in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and
AR. Cancer Biol Ther. 21:34–42. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mercatelli N, Coppola V, Bonci D, Miele F,
Costantini A, Guadagnoli M, Bonanno E, Muto G, Frajese GV, De Maria
R, et al: The inhibition of the highly expressed miR-221 and
miR-222 impairs the growth of prostate carcinoma xenografts in
mice. PLoS One. 3(e4029)2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6(pl1)2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Laengsri V, Kerdpin U, Plabplueng C,
Treeratanapiboon L and Nuchnoi P: Cervical cancer markers:
Epigenetics and microRNAs. Lab Med. 49:97–111. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Luhn P, Walker J, Schiffman M, Zuna RE,
Dunn ST, Gold MA, Smith K, Mathews C, Allen RA, Zhang R, et al: The
role of co-factors in the progression from human papillomavirus
infection to cervical cancer. Gynecol Oncol. 128:265–270.
2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chung SH, Wiedmeyer K, Shai A, Korach KS
and Lambert PF: Requirement for estrogen receptor alpha in a mouse
model for human papillomavirus-associated cervical cancer. Cancer
Res. 68:9928–9934. 2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chung SH, Franceschi S and Lambert PF:
Estrogen and ERalpha: Culprits in cervical cancer? Trends
Endocrinol Metab. 21:504–511. 2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lopez-Romero R, Garrido-Guerrero E,
Rangel-Lopez A, Manuel-Apolinar L, Piña-Sánchez P, Lazos-Ochoa M,
Mantilla-Morales A, Bandala C and Salcedo M: The cervical malignant
cells display a down regulation of ER-α but retain the ER-β
expression. Int J Clin Exp Pathol. 6:1594–1602. 2013.PubMed/NCBI
|
|
32
|
Zhai Y, Bommer GT, Feng Y, Wiese AB,
Fearon ER and Cho KR: Loss of estrogen receptor 1 enhances cervical
cancer invasion. The American journal of pathology. 177:884–895.
2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Deligeoroglou E, Michailidis E and
Creatsas G: Oral contraceptives and reproductive system cancer.
Annals of the New York Academy of Sciences. 997:199–208.
2003.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Miller N, Bedard YC, Cooter NB and Shaul
DL: Histological changes in the genital tract in transsexual women
following androgen therapy. Histopathology. 10:661–669.
1986.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Jiang H, Yu WW, Wang LL and Peng Y:
miR-130a acts as a potential diagnostic biomarker and promotes
gastric cancer migration, invasion and proliferation by targeting
RUNX3. Oncology reports. 34:1153–1161. 2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Liu SG, Qin XG, Zhao BS, et al:
Differential expression of miRNAs in esophageal cancer tissue.
Oncology letters. 5:1639–1642. 2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Chi C, Mao M, Shen Z, Chen Y, Chen J and
Hou W: HOXD-AS1 Exerts Oncogenic Functions and Promotes
Chemoresistance in Cisplatin-Resistant Cervical Cancer Cells. Human
gene therapy. 29:1438–1448. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hofsjo A, Bohm-Starke N, Bergmark K,
Masironi B and Sahlin L: Sex steroid hormone receptor expression in
the vaginal wall in cervical cancer survivors after radiotherapy.
Acta oncologica. 58:1107–1115. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhang HD, Jiang LH, Sun DW, Li J and Ji
ZL: The role of miR-130a in cancer. Breast cancer. 24:521–527.
2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Yin S, Zhang Q, Wang Y, Li S and Hu R:
MicroRNA-130a regulated by HPV18 E6 promotes proliferation and
invasion of cervical cancer cells by targeting TIMP2. Experimental
and therapeutic medicine. 17:2837–2846. 2019.PubMed/NCBI View Article : Google Scholar
|
